Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: CSR, SRI

Solomon Page Announces Charitable Initiative To Support The New York State COVID-19 First Responders Fund


NEW YORK, April 14, 2020 /PRNewswire/ -- Solomon Page announces a charitable initiative in support of frontline workers during the COVID-19 pandemic. With corporate headquarters based in the epicenter of the disease, the firm has expanded its 2020 charitable contributions to support the relief efforts of healthcare workers during this time of crisis.

In conjunction with Governor Cuomo's announcement of the First Responders Fund, Solomon Page will be contributing 5% of its quarterly profit in support of the cause. "We hope that through this donation we can make a deeper impact within the communities we serve," said Founding Partner Lloyd Solomon. "In the days, weeks, and possibly months ahead, we will continue to advocate for those in need and support these individuals in getting through some of the most challenging times our nation has ever faced."   

With offices nationwide, Solomon Page will be identifying additional non-profit organizations to support during the COVID-19 pandemic. "It is crucial that our frontline workers have access to the resources they need," said Co-founder Scott Page. "The effects of this disease will continue to be detrimental ? and it is our obligation to do whatever it takes to mitigate the impact."

About Solomon Page
Founded in 1990, Solomon Page is a specialty niche provider of recruitment and executive search solutions across a wide array of functions and industries. The success of Solomon Page reflects an organic growth strategy supported by a highly entrepreneurial culture. Acting as a strategic partner to clients and candidates, Solomon Page focuses on providing customized solutions and building long-term relationships based on trust, respect, and the consistent delivery of excellent results. For additional information, visit solomonpage.com.

SOURCE Solomon Page


These press releases may also interest you

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:19
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...



News published on and distributed by: